Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
2nd.MD is a digital health company that provides employer- and health plan-sponsored expert medical opinions and care-navigation services, connecting members with board-certified specialists by video or phone. The company focuses on second opinions, diagnostic clarification, treatment decision support, and surgical review across a broad range of adult and pediatric conditions rather than developing therapeutics. Founded in Houston, 2nd.MD built a concierge-style model in which its care team gathers records and coordinates specialist consultations within days. The company was acquired by Accolade in March 2021, and its capabilities later became part of the combined Transcarent/Accolade organization following the April 8, 2025 merger. 2nd.MD remains an active branded service and website for expert medical consultation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 2nd.MD.